Key Takeaways
Treat the gut as a possible immune control room, not a proven cure
A different starting point. Rebecca Fett’s search began with her own illness: after years of worsening joint pain, a return of psoriasis helped reveal likely psoriatic arthritis. Her earlier improvement after removing gluten had not settled the problem. She turned from symptom control alone toward research on the gut, immune system, and microbiome. The book’s central proposal is that gut problems may help sustain inflammation beyond the digestive tract.
The proposed pathway. Increased intestinal permeability means the gut lining lets more bacterial products or incompletely digested proteins pass through. Immune cells near the lining can react, producing signals that contribute to inflammation elsewhere, including skin and joints. The book cites colonoscopy studies finding intestinal inflammation in about half of some people with psoriasis or related arthritis, even without bowel symptoms. That suggests a possible connection, not proof that gut changes cause every case.
What's valuable is the shift from asking only how to suppress inflammation to asking what may be repeatedly provoking it. That question fits systems biology, where symptoms in one organ can reflect signals from another. But a plausible pathway is not a settled explanation for an individual patient. Gut inflammation may be a driver, a consequence, or both, and autoimmune diseases have multiple causes. The author's personal improvement makes the investigation vivid, but one person's course cannot establish which dietary changes produced the change or predict another person's response.
Restore the gut's keystone microbes, rather than chasing inflammation alone
Balance beats a single culprit. The book calls certain bacteria “keystone species” because their presence can disproportionately shape the gut ecosystem. It focuses on butyrate-producing bacteria, including members of Clostridia clusters IV and XIVa, which are often reduced in studies of inflammatory bowel disease, psoriasis, and arthritis. Butyrate is a short-chain fatty acid made when microbes ferment fiber. The book describes it as supporting the gut lining and helping immune cells develop into regulatory T cells, which restrain excessive immune activity.
The other side of imbalance. Some potentially harmful species, including certain E. coli, Klebsiella, and Streptococcus, may damage the barrier or activate immune responses. The book’s aim is to support protective microbes while limiting inflammatory ones, not to eradicate all bacteria. Findings differ by disease and study, so the presence of a named species alone cannot diagnose the cause of someone’s symptoms.
The ecosystem metaphor is stronger than the familiar good-bacteria versus bad-bacteria story. Microbes interact, compete, and exchange metabolites, so the same organism may matter differently depending on its neighbors and the host environment. That makes broad claims about a single “culprit” less convincing than attention to community patterns and function. It also explains why a stool report naming one species should not be mistaken for a complete biological portrait. The useful question is not simply which microbes are present, but what the whole community is doing.
Feed microbial allies with diverse plants, not supplements alone
Fiber becomes a microbial resource. The Keystone Approach emphasizes fermentable fiber, especially from vegetables and fruit, because gut microbes turn it into compounds such as butyrate. The book highlights cruciferous vegetables, apples, pears, and other varied produce. It also points to polyphenols in deeply colored fruit, including cranberries, pomegranates, and dark berries, as possible support for beneficial microbes. Its argument is that food can change the resources available to the gut community, not just provide calories and nutrients.
A striking comparison. In a study described in the book, children in rural Burkina Faso eating a fiber-rich diet had gut butyrate levels about four times those of European children. A separate two-week diet switch increased butyrate in the high-fiber group. These results support diet’s influence on microbial activity, but do not prove that the same changes resolve autoimmune disease in every person.
This is one of the book’s most practical ideas because it links a daily choice to a biological mechanism: what reaches the colon helps determine which microbes can thrive. It also avoids making probiotics the whole story. Still, “more fiber” is not automatically comfortable or appropriate for everyone, particularly when gut symptoms are active. The book itself recognizes that fermentable fibers can have variable effects. A gradual increase, with attention to symptoms and nutritional adequacy, is more sensible than treating one fiber target as universally beneficial.
Use starch reduction as a measured experiment, not a universal rule
Start with the condition and the response. The book proposes three low-starch levels rather than one rigid menu. Its basic plan removes gluten-containing grains and selected foods such as corn, soy, peanuts, quinoa, and potatoes, while allowing limited portions of other starches. The intermediate plan removes grains, legumes, and very starchy vegetables. The advanced plan sharply limits starch and is presented chiefly for ankylosing spondylitis, with carbohydrates often below 50 to 60 grams daily.
Why test it. The proposed rationale is that starch may feed bacteria implicated in some gut-related inflammation, including Klebsiella and certain E. coli. A small study of 10 children with inflammatory bowel disease on the Specific Carbohydrate Diet found eight in remission after three months. That is encouraging, but a small study is not a guarantee. The book recommends assessing symptoms over time and testing whether a less restrictive level is tolerated.
The graduated structure is more defensible than declaring one exclusion diet right for everyone. It frames restriction as a testable hypothesis: change one broad exposure, track outcomes, and avoid unnecessary long-term limits if there is no benefit. Yet the evidence supporting strict starch avoidance is uneven, and symptom improvement can reflect several simultaneous changes, including reduced processed food or altered energy intake. Restrictive diets also carry practical and nutritional costs. A clinician or dietitian can help keep an experiment safe, especially for children or people with active disease.
Build meals around fish, olive oil, and colorful vegetables
Choose fats with intention. The book’s dietary foundation resembles a Mediterranean pattern: vegetables, fish, olive oil, and leaner proteins. It emphasizes EPA and DHA, the omega-3 fats found in fish, and the monounsaturated fats and antioxidant compounds in extra-virgin olive oil. Salmon, sardines, Atlantic mackerel, and herring are highlighted as useful fish choices. The author contrasts these with frequent use of refined seed oils and added saturated fats such as coconut oil, butter, and lard, which she argues may promote inflammatory signaling.
Human evidence, with limits. A three-month Mediterranean-diet study involving 50 people with rheumatoid arthritis reported improvements in joint symptoms and inflammation measures. The book also cites studies of fish oil in psoriasis and arthritis. These findings support a food pattern as an adjunct, not a replacement for treatment. The claim that all saturated fats meaningfully worsen autoimmune disease is more contestable than the broader case for a nutrient-rich dietary pattern.
This advice has the advantage of being a positive pattern rather than a long list of forbidden foods. Fish, olive oil, and vegetables can improve overall dietary quality even if the proposed immune mechanisms prove incomplete. The evidence is strongest when interpreted at the level of a whole eating pattern, because foods arrive in combinations and diets are difficult to isolate experimentally. The sharper claims about individual fats deserve more caution: short controlled studies can reveal biological effects without showing that a specific oil worsens a person’s clinical disease.
Choose probiotics by strain and purpose, not the biggest label
Strains are not interchangeable. The book argues that a probiotic’s effects depend on its specific strain, not merely its species or the number of organisms listed on the package. It highlights Bifidobacteria for supporting other microbes through “cross-feeding,” in which one bacterium’s by-products become another’s fuel. It also discusses Lactobacillus rhamnosus GG and specific products studied for pathogen suppression or gut-barrier support. The book sorts options into introductory, stronger, and short-term pathogen-focused categories, but these are its proposed guide, not a universal clinical standard.
Fiber supplements can cut both ways. Prebiotics are fibers intended to feed selected microbes. The book compares them to fertilizer: they may nourish helpful bacteria, but can also feed unwanted species. Acacia fiber is presented as relatively well tolerated, while concentrated inulin or FOS may be less suitable for some people. Evidence varies by product, strain, and condition, and some findings cited are not from trials in autoimmune disease.
The emphasis on strain specificity is a useful corrective to probiotic marketing, which can make unrelated products sound equivalent. It also captures an important ecological idea: adding an organism is not the same as rebuilding a community, and the result depends on what else is present. The limitation is that evidence for one strain in infants, diarrhea, or bowel disease does not automatically transfer to arthritis or psoriasis. A product’s clinical evidence should match both its exact strain and the outcome being claimed.
For suspected SIBO, support gut clearance rather than only killing bacteria
The small intestine has a cleaning rhythm. Small intestinal bacterial overgrowth, or SIBO, means excess bacteria in the small intestine, where bacterial numbers are normally lower than in the colon. The book describes the migrating motor complex, a recurring pattern of gut contractions that moves residue through the small intestine between meals. Eating repeatedly may interrupt this activity. The author therefore suggests defined meals, spaced roughly four to five hours apart, as one way to support normal clearance, alongside assessment of digestion and gut motility.
Treatment can relapse. The book notes that antibiotics such as rifaximin can help SIBO, but cites a study in which 40 percent of patients relapsed within nine months. Breath tests are imperfect, and the cause of overgrowth matters. This is not a reason to refuse necessary antibiotics or treat suspected SIBO without medical guidance. The book’s argument is to consider the underlying factors as well as the overgrowth itself.
The clearance concept makes the timing of meals part of digestive physiology rather than merely a weight-management tactic. It also encourages attention to why an overgrowth returns, a general principle shared by infectious-disease treatment: removing a problem temporarily is different from changing the conditions that favor it. But meal spacing is not appropriate for every person, and the book’s proposed interval should not be treated as a proven autoimmune therapy. Persistent digestive symptoms warrant clinical evaluation, not just self-diagnosis from a symptom list.
Find personal triggers with disciplined elimination and reintroduction
Test rather than guess. The book proposes temporarily removing possible triggers such as dairy, eggs, nuts, and nightshade vegetables, then adding foods back one at a time while monitoring symptoms. Nightshades include tomatoes, potatoes, peppers, and eggplant. The purpose is to discover whether a particular food reliably affects an individual, not to label these foods harmful for everyone. The book recommends allowing time for symptoms to settle between challenges and avoiding food challenges in anyone with a history of severe allergic reactions.
Tests have limits. It describes IgE testing for conventional food allergy and notes that IgG food-sensitivity tests can produce false positives and may reflect exposure rather than a true harmful reaction. A structured elimination and reintroduction can provide useful observations, but symptoms are vulnerable to expectation, natural flares, and other simultaneous changes. A food diary and professional guidance can make the results more interpretable and help prevent needless dietary restriction.
This is the book’s clearest version of an N-of-1 experiment: an individual tests a specific exposure against their own symptoms. Reintroduction matters because otherwise improvement during restriction may be wrongly attributed to every excluded food. Blinding is difficult in ordinary life, so expectations can influence what people notice; repeated, consistent reactions are more informative than a single bad day. The approach is most useful when focused and time-limited. Broad elimination without a plan can shrink the diet while producing little reliable knowledge.
Treat supplements and low-dose naltrexone as clinician-guided adjuncts
Support is not substitution. The book discusses vitamin D, fish oil, glucosamine, and a more absorbable curcumin formulation as possible additions, while emphasizing that supplements vary in evidence and quality. It also describes low-dose naltrexone, a prescription drug used off-label in some settings. Small studies in Crohn’s disease reported intestinal improvement, and the book proposes that blocking immune responses to bacterial products could be relevant to other inflammatory conditions. Evidence for using it in arthritis or psoriasis was still developing in the text.
Keep medical care central. The book explicitly says dietary changes and supplements should complement prescribed treatment, not replace it. Supplements can interact with medications, and low-dose naltrexone cannot be combined with opioids. Vitamin D status and high-dose supplementation require care, too. The author’s broader point is that supportive interventions may improve disease management, but decisions about medication, tests, or supplements belong with a qualified clinician.
The distinction between adjunct and replacement is essential, especially because the book’s confident tone can make emerging mechanisms sound clinically established. A promising pathway, such as a proposed effect on a bacterial-sensing receptor, is a reason to study a treatment, not evidence that it works for every related disease. Supplements also pose a measurement problem: adding several at once makes benefit and harm hard to attribute. One change at a time, with medication review and appropriate monitoring, protects both safety and the value of the experiment.
Analysis
The Keystone Approach is a science-informed health guide with a personal narrative, a biological hypothesis, and a practical dietary program. Its organizing idea is that gut-barrier disruption and microbial imbalance may help drive inflammation in psoriasis, spondyloarthritis, and related conditions. From there, it builds an intervention logic: support fiber-fermenting microbes, reduce possible microbial fuel, choose fats the author considers less inflammatory, investigate individual food triggers, and use selected probiotics or supplements as additions to standard care.
The strongest contribution is its insistence that diet and the microbiome deserve investigation rather than dismissal. It makes a complex gut-to-immune pathway intelligible, distinguishes microbial communities from a single “bad” bacterium, and gives readers a framework for testing changes rather than following every popular elimination diet. Its food-pattern advice, especially emphasizing vegetables, fish, and olive oil, is more broadly grounded than its most restrictive protocols.
The evidence needs to be read in layers. The book draws on a mix of human trials, observational associations, small studies, animal experiments, and mechanistic hypotheses. Those forms of evidence do not carry equal weight. Microbial differences observed in people with disease may be causes, consequences, or both; success in a small bowel-disease study does not establish effectiveness for arthritis. The author's own recovery is meaningful as a personal account, not proof of a general cure. Likewise, highly restrictive diets, specific probiotic products, antimicrobial supplements, and low-dose naltrexone require more caution than the book’s overall hypothesis.
The source text reflects research and claims available around 2017-2018, not a current clinical guideline. Its practical value is best understood as a menu of questions for a clinician and carefully monitored personal experiments, not a replacement for diagnosis or disease-modifying treatment. The book itself makes this distinction: changes are intended to work alongside conventional care, and medication changes should be made with a doctor.
People Also Read
Glossary
Keystone Approach
Gut-focused autoimmune strategyThe author’s proposed plan for addressing autoimmune inflammation by supporting the gut barrier and microbiome through food choices, selected probiotics, and other possible adjuncts. It combines general measures, such as emphasizing vegetables and fish, with individualized trials of starch reduction and suspected trigger foods. The book presents it as complementary to conventional medical care.
Keystone species
Microbes with ecosystem-wide effectsA species whose role has a disproportionately large influence on the wider ecosystem. In this book, the term describes gut microbes that help regulate immune activity or support other beneficial bacteria. The concept does not mean that one bacterial species alone determines health; its effects depend on its relationships with other microbes and the host.
Dysbiosis
Disrupted microbial community balanceAn imbalance in the composition or function of a microbial community. The book uses the term for patterns reported in some autoimmune and inflammatory conditions, including fewer bacteria associated with butyrate production and more species thought to activate inflammation. Dysbiosis is a description of a pattern, not by itself proof of a disease cause or a treatment target.
Butyrate
Fiber-derived microbial fatty acidA short-chain fatty acid produced when gut microbes ferment certain fibers. The book emphasizes butyrate because it can provide energy to cells lining the intestine and act as a signal involved in immune regulation, including the development of regulatory T cells. Levels depend on diet and microbial activity, and a change in butyrate alone does not establish clinical improvement.
Small intestinal bacterial overgrowth
Excess bacteria in small intestineOften abbreviated SIBO, this is an excess of bacteria in the small intestine, where bacterial numbers are normally relatively low. The book proposes that bacterial products in this location may cross the intestinal wall and contribute to inflammation. Breath tests can be used to investigate SIBO, but the text notes that these tests can miss cases and be difficult to interpret.
Migrating motor complex
Between-meal intestinal clearing cycleA recurring pattern of contractions in the digestive tract that moves residue through the small intestine between meals. The book describes it as a natural clearing process that is interrupted when eating resumes. It uses this mechanism to explain its recommendation to leave several hours between meals, while recognizing that SIBO may have multiple causes.
Specific Carbohydrate Diet
Diet restricting selected carbohydratesA dietary pattern that removes starch and certain two-unit sugars, including lactose and sucrose, while allowing some simpler sugars from foods such as fruit and honey. As described in the book, the aim is to reduce carbohydrates that may remain in the intestine and feed microbes. The text discusses promising inflammatory bowel disease findings but does not establish universal benefit.
Low-dose naltrexone
Off-label low-dose prescription drugNaltrexone is a prescription medication used at much lower doses than those used for addiction treatment in some experimental or off-label approaches to chronic pain and inflammation. The book reviews studies in multiple sclerosis, fibromyalgia, and Crohn’s disease, and discusses a possible effect on immune responses to bacterial products. It is not presented as an approved autoimmune treatment and cannot be combined with opioids.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.